Modulation of the mesolimbic dopamine system by glutamate: Role of NMDA receptors

Journal of Neurochemistry

Volumn 73, Issue 2, 1999, Pages 839-848

  Kretschmer, Beate D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Dopamine; Glutamate; Microdialysis; Motor behavior; N Methyl D aspartate; Ventral tegmental area

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 5 PHOSPHONOVALERIC ACID; AMPA RECEPTOR; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; DOPAMINE RELEASE; HISTOLOGY; LIMBIC CORTEX; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; VENTRAL TEGMENTUM;

2-AMINO-5-PHOSPHONOVALERATE; 3,4-DIHYDROXYPHENYLACETIC ACID; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HOMOVANILLIC ACID; LIMBIC SYSTEM; MALE; MICRODIALYSIS; MOTOR ACTIVITY; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; VENTRAL TEGMENTAL AREA;

ANIMALIA;

EID: 0032771328     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730839.x     Document Type: Article

References (78)

1. Al-Khatib I., Karadag H. C., and Ulugol A. (1995) The behavioral effects of MK-801 injected into nucleus accumbens and caudateputamen of rats. Pharmacol. Biochem. Behav. 52, 723-730.
2. Boldry R. C., Layer R. T., Wallace L. J., and Uretsky N. J. (1992) Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions. Neurosci. Lett. 138, 265-269.
3. Brudzynski S. M., Wu M., and Mogenson G. J. (1993) Decrease in rat locomotor activity as a result of changes in synaptic transmission to neurons within the mesencephalic locomotor region. Can. J. Physiol. Pharmacol. 71, 394-406.
4. Bubser M., Keseberg U., Notz P. K., and Schmidt W. J. (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur. J. Pharmacol. 229, 75-82.
5. Bubser M., Zadow B., Kronthaler U. O., Felsheim U., Rueckert N. G. H., and Schmidt W. J. (1997) Behavioral pharmacology of the non-competitive NMDA antagonists dextrophan and ADCI: relations between locomotor stimulation, anti-cataleptic potential and forebrain dopamine metabolism. Naunyn Schmiedebergs Arch. Pharmacol. 355, 767-773.
6. Carlsson M. and Carlsson A. (1989) The NMDA antagonist MK 801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 75, 221-226.
7. Ceci A. and French E. D. (1989) Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesion of the nucleus accumbens and medial prefrontal cortex. Life Sci. 45, 637-646.
8. Cheramy A., Leviel V., and Glowinski J. (1981) Dendritic release of dopamine in the substantia nigra. Nature 289, 537-542.
9. Chergui K., Charlety P. J., Akaoka H., Saunier C. F., Brunet J. L., Buda M., Svensson T. H., and Chouvet G. (1993) Tonic activation of NMDA receptor causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5, 137-144.
10. Clineschmidt B. V., Martin G. E., and Bunting P. R. (1982) Anticonvulsant activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev. Res. 2, 123-134.
11. Danysz W., Essman U., Bresink I., and Wilke R. (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48, 111-118.
12. Druhan J. P., Rajabi H., and Stewart J. (1996) MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse 24, 135-146.
13. Evans R. H., Francis A. A., Jones A. W., Smith D. A., and Watkins J. C. (1982) The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations. Br. J. Pharmacol. 75, 65-75.
14. Fagg G. E., Olpe H. R., Pozza M. F., Baud J., Steinmann M., Schmutz M., Portet C., Baumann P., Thedinga K., Bittiger H., Allgeier H., Heckendorn R., Angst C., Brundish D., and Dingwall J. G. (1990) CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br. J. Pharmacol. 99, 791-797.
15. Freeman A. S. and Bunney B. S. (1984) The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur. J. Pharmacol. 104, 287-293.
16. French E. D. (1986) Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat. Neuropharmacology 25, 241-248.
17. French E. D. (1992) Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons. Eur. J. Pharmacol. 271, 1-7.
18. French E. D. (1994) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol. Teratol. 16, 355-362.
19. French E. D., Ferkany J., Abreu M., and Levenson S. (1991) Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology 30, 1039-1046.
20. French E. D., Mura A., and Wang T. (1993) MK-801, phencyclidine (PCP) and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive antagonists. Synapse 13, 108-116.
21. Gonon F. G. and Buda M. J. (1985) Regulation of dopamine release by impulse flow and dopamine autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience 14, 764-774.
22. Graybiel A. M. (1997) The basal ganglia and cognitive pattern generators. Schizophr. Bull. 23, 459-469.
23. Grenhoff J., Tung C. S., and Svensson T. H. (1988) The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 134, 567-568.
24. Huettner J. E. and Bean B. B. P. (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc. Natl. Acad. Sci. USA 85, 1307-1311.
25. A receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J. Neurochem. 69, 137-143.
26. Imperato A., Honor T., and Jensen L. H. (1990a) Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Res. 530, 223-228.
27. Imperato A., Scrocco M. G., Bacchi S., and Angelucci L. (1990b) NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187, 555-556.
28. Kalivas P. W. and Duffy P. (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56, 961-967.
29. Kaneman M., Westerink B. H. C., and Moghaddam B. (1996) Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum. J. Neurochem. 67, 601-607.
30. Kelley A. E. and Throne L. C. (1992) NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29, 247-254.
31. Kretschmer B. D. and Schmidt W. J. (1996) Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens. J. Neurosci. 16, 1561-1569.
32. Kretschmer B. D., Zadow B., Volz T. L., Volz L., and Schmidt W. J. (1992) The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior. J. Neural Transm. 87, 23-35.
33. Krogsgaard-Larsen P., Honore T., Hansen J. J., Curtis D. R., and Lodge D. (1980) New class of glutamate agonist structurally related to ibotenic acid. Nature 284, 64-66.
34. Lehmann J., Loo P., McPherson S., French-Mullen J. M. H., Steel D., Braunwalder A., Williams M., and Wood P. L. (1987a) NMDA- and PCP-type receptor interactions: allosteric mechanism at a common macromolecular complex, in Excitatory Amino Acid Transmission (Lodge D., Hicks T. P., and McLennan H., eds), pp. 91-98. Liss, New York.
35. Lehmann J., Schneider J., McPherson S., Murphy D., Bernard P., Tsai C., Bennett D., Pastor G., Steel D. J., Boehm C., Cheney D. L., Liebmann J. M., Williams M., and Wood P. L. (1987b) CPP, a selective NMDA-type receptor antagonist: characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 240, 737-746.
36. Lowe D. A., Emre M., Frey P., Kelly P. H., Malanowski J., McAllister K. H., Neijt H. C., Rudeberg C., Urwyler S., White T. G., and Herding P. L. (1994) The pharmacology of SDZ EAA 494, a competitive NMDA antagonist. Neurochem. Int. 25, 583-600.
37. Mathe J. M., Nomikos G. G., Hildebrand B. E., Hertel P., and Svensson T. H. (1996) Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 309, 1-11.
38. McCullough L. D. and Salamone J. D. (1992) Increase in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res. 577, 1-9.
39. Mogenson G. J. (1987) Limbic-motor integration, in Progress in Psychobiology and Physiological Psychology (Epstein A. M. and Morrison A. R., eds), pp. 117-170. Academic Press, San Diego.
40. Murase S., Grenhoff J., Chouvet G., Gonon F. G., and Svensson T. H. (1993a) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157, 53-56.
41. Murase S., Math J. M., Grenhoff J., and Svensson T. H. (1993b) Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J. Neural Transm. 91, 13-25.
42. O'Neill K. A., Carelli R. M., Jarvis M. F., and Liebman J. M. (1989) Hyperactivity induced by N-methyl-D-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons. Pharmacol. Biochem. Behav. 34, 739-745.
43. Ouagazzal A. and Amalric M. (1995) Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism. Eur. J. Pharmacol. 294, 137-146.
44. Ouagazzal A., Nieoullon A., and Amalric M. (1994) Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Eur. J. Pharmacol. 251, 229-236.
45. Parada-Turska J. and Turski W. A. (1990) Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29, 1111-1116.
46. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
47. Pellegrino L. J., Pellegrino A. S., and Cushman A. J. (1986) A Stereotoxic Atlas of the Rat Brain. Plenum Press, New York.
48. Pennartz C. M. A., Groenewegen H. J., and Lopes da Silva F. H. (1994) The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42, 719-761.
49. Raffa R. B., Ortegon M. E., Robisch D. M., and Martin G. E. (1989) In vivo demonstration of the enhancement of MK-801 by L-glutamate. Life Sci. 44, 1593-1599.
50. Rao T. S., Contreras P. C., and Wood P. L. (1990a) Are N-methyl-D-aspartate (NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other? Neurochem. Int. 17, 1-8.
51. Rao T. S., Kim H. S., Lehmann J., Martin L. L., and Wood P. L. (1990b) Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. J. Neurochem. 54, 1157-1162.
52. Rao T. S., Cler J. A., Mick S. J., Emmett M. R., Farah J. M. Jr., Contreras P. C., Iyengar S., and Wood P. L. (1991a) Neurochemical interaction of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway. J. Neurochem. 56, 907-913.
53. Rao T. S., Contreras P. C., Cler J. A., Mick S. J., Dilworth V. M., Iyengar S., Monahan J. B., and Wood P. L. (1991b) Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites. J. Neurochem. 56, 890-897.
54. Rice M. E., Cragg S. J., and Greenfield S. A. (1997) Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J. Neurophysiol. 77, 853-862.
55. Santiago M. and Westerink B. H. (1992) Simultaneous recording of the release of nigral and striatal dopamine in the awake rat. Neurochem. Int. 20 (Suppl.), 107S-110S.
56. Schmidt C. J. and Fadayel G. M. (1996) Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. J. Pharmacol. Exp. Ther. 277, 1541-1549.
57. Schmidt W. J. (1986) Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90, 123-130.
58. Schmidt W. J. (1995) Balance of transmitter activities in the basal ganglia loops. J. Neural Transm. 46 (Suppl.), 67-76.
59. Schmidt W. J. and Kretschmer B. D. (1997) Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci. Biobehav. Rev. 21, 381-392.
60. Shimizu N., Duan S., Hori T., and Oomura Y. (1990) Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res. Bull. 25, 99-102.
61. Suaud-Chagny M. F., Chergui K., Chouvet G., and Gonon F. (1992) Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acid in the ventral tegmental area. Neuroscience 49, 63-72.
62. Sulzer D., Joyce M. P., Lin L., Geldwert D., Haber S., Hattori T., and Rayport S. (1998) Dopamine neurons make glutamatergic synapses in vitro. J. Neurosci. 18, 4588-4602.
63. Svensson A., Pileblad E., and Carlsson M. M. (1991) A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. J. Neural Transm. 85, 117-159.
64. Swanson L. W. (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9, 321-353.
65. Taber M. T. and Fibiger H. C. (1995) Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15, 3896-3904.
66. Tiedtke P. I., Bischoff C., and Schmidt W. J. (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J. Neural Transm. 81, 173-182.
67. Ungerstedt U., Herrera-Marschitz M., Jungnelius U., Stahle L., Tossman U., and Zetterstroem T. (1982) Dopamine synaptic mechanisms reflected in studies combining behavioral recordings and brain dialysis. Adv. Biosci. 37, 219-231.
68. van Bockstaele E. J. and Pickel V. M. (1995) GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 682, 215-221.
69. Watkins J. C. and Evans R. H. (1981) Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21, 165-204.
70. Westerink B. H. C., Kwint H. F., and de Vries J. B. (1996) The pharmacology of mesolimbic dopamine neurons: a dual probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16, 2605-2611.
71. White F. J. and Wang R. Y. (1984) Pharmacological characterization of dopamine autoreceptors in rat ventral tegmental area: microiontophoretic studies. J. Pharmacol. Exp. Ther. 231, 275-280.
72. Willins D. L., Narayanan S., Wallace L. J., and Uretsky N. J. (1993) The role of dopamine and AMPA/kainate receptor in the nucleus accumbens in the hypermotility response to MK-801. Pharmacol. Biochem. Behav. 46, 881-887.
73. Wolf M. E. (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720.
74. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., and Iversen L. L. (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83, 7104-7108.
75. Yan Q. S., Reith M. E. A., Jobe P. C., and Dailey J. W. (1997) Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 765, 149-158.
76. Yoshida M., Yokoo H., Tanaka T., Emoto H., and Tanaka M. (1994) Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636, 111-114.
77. Youngren K. D., Daly D. A., and Moghaddam B. (1993) Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther. 264, 289-293.
78. Zhang J., Chiodo L. A., and Freeman A. S. (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res. 590, 153-163.